NDC 70860-781-41 - Glycopyrrolate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70860-781
- Requested NDC
- 70860-781-41
- Package NDCs from labels
- 70860-781-41, 70860-781-01, 70860-781-42, 70860-781-02, 70860-781-43, 70860-781-05, 70860-781-44, 70860-781-20
- Manufacturer
- Athenex Pharmaceutical Division, LLC.
- Effective date
- 2025-01-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYCOPYRROLATE INJECTION, USP | Athenex Pharmaceutical Division, LLC. | 2025-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 70860-781-01 | 2024-03-03 | GLYCOPYRROLATE INJECTION, USP |
| 70860-781-02 | 2024-03-03 | GLYCOPYRROLATE INJECTION, USP |
| 70860-781-05 | 2024-03-03 | GLYCOPYRROLATE INJECTION, USP |
| 70860-781-20 | 2024-03-03 | GLYCOPYRROLATE INJECTION, USP |
| 70860-781-01 | 2024-01-30 | GLYCOPYRROLATE INJECTION, USP |
| 70860-781-02 | 2024-01-30 | GLYCOPYRROLATE INJECTION, USP |
| 70860-781-05 | 2024-01-30 | GLYCOPYRROLATE INJECTION, USP |
| 70860-781-20 | 2024-01-30 | GLYCOPYRROLATE INJECTION, USP |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70860-781-01 | ML - Milliliter | 70860-781 | 3834fb8e-055f-4691-8172-ad274c6ccb10 | 1 | 2023-12-05 |
| 70860-781-02 | ML - Milliliter | 70860-781 | f47612e8-abfb-4e7d-8636-026aaa421298 | 1 | 2024-06-10 |
| 70860-781-05 | ML - Milliliter | 70860-781 | a3581a63-b43f-4e23-948b-9d82e63631b9 | 1 | 2023-12-05 |
| 70860-781-20 | ML - Milliliter | 70860-781 | 4cd125ee-5483-4569-bf0d-d90eb9410246 | 1 | 2023-12-05 |
| 70860-781-41 | ML - Milliliter | 70860-781 | 9f56f1ac-c461-4f22-8397-e2b61f2f2926 | 1 | 2023-12-05 |
| 70860-781-42 | ML - Milliliter | 70860-781 | 64f7bd2d-9942-4ff6-a34b-2387bddb5313 | 1 | 2024-06-10 |
| 70860-781-43 | ML - Milliliter | 70860-781 | 107bddd2-06ff-4f1d-bc7f-979232582124 | 1 | 2023-12-05 |
| 70860-781-44 | ML - Milliliter | 70860-781 | ed4b6784-37b3-4ece-a149-c6eb19263859 | 1 | 2023-12-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLYRX-PF | GLYCOPYRROLATE | Exela Pharma Sciences, LLC | 2189f3f5-39dc-4e85-b7c6-9515ded59686 | 2025-07-23 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | QUAGEN PHARMACEUTICALS LLC | a456eaea-4cd6-4344-8fc6-6f6a3ce0f2c6 | 2025-06-14 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | American Health Packaging | 6404fc8e-d109-4950-9dca-c8a85ad90cf3 | 2025-05-18 | Warnings, Adverse reactions | V92SO9WP2I |
| Eyesaline Emergency Eyewash | STERILE EYESALINE EYEWASH | Honeywell Safety Products USA, Inc. | 2d567518-4c54-7448-e063-6294a90a3e64 | 2025-05-14 | Warnings | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Leading Pharma, LLC | 498bce66-6072-4212-8413-ff9888c58f9c | 2025-04-25 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Chartwell RX, LLC | 89090b34-470c-478c-be49-1d2bc48a28f8 | 2025-04-17 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Aurobindo Pharma Limited | 4b3f8b3e-6fa8-471b-8bee-3dac5e3ea1b8 | 2025-04-17 | Warnings, Adverse reactions | V92SO9WP2I |
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | AvPAK | bd497783-e2d1-130c-e053-2995a90a7fb9 | 2025-03-04 | Warnings, Adverse reactions | V92SO9WP2I |
| AeroWash Eyewash | EYEWASH SOLUTION | Aero Healthcare US LLC | a477de08-4301-0ee5-e053-2995a90af79d | 2025-02-26 | Warnings | 059QF0KO0R |
| Advanced Eye Relief Eye Wash | WATER SOLUTION | Bausch & Lomb Incorporated | 9caccce1-4530-441d-bf76-244edeb9dedc | 2025-02-17 | Warnings | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products, Inc. | 2d90c8e8-f479-3535-e063-6394a90af122 | 2025-02-07 | Warnings | 059QF0KO0R |
| 2cc9bce0-af74-e52c-e063-6394a90aba8d | c444d63b-f394-4ae5-a74d-50105a406574 | 2025-01-28 | Warnings, Adverse reactions | 2cc9bce0-af74-e52c-e063-6394a90aba8d c444d63b-f394-4ae5-a74d-50105a406574 | ||
| Glycopyrrolate | GLYCOPYRROLATE | Caplin Steriles Limited | 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2025-01-25 | Warnings, Adverse reactions | V92SO9WP2I |
| Medics Choice Soothing Eye Wash | PURIFIED WATER | KC Pharmaceuticals, Inc. | 10e49808-161e-f4ec-e063-6294a90a1775 | 2025-01-19 | Warnings | 059QF0KO0R |
| D-114 | ALUMINUM METALLICUM, AILANTHUS, BAPTISIA TINCTORIA, FRAGARIA VESCA, YOSCYAMUS NIGER, MURIATICUM ACID | DNA Labs | f6f7d369-64ef-0ed9-e053-6294a90a40fa | 2025-01-13 | Warnings | QTT17582CB |
| STERILE WATER | STERILE WATER | HF Acquisition Co. LLC, DBA HealthFirst | 74ed2a6f-824c-a1ff-e053-2a91aa0a57c0 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 77bd3c0f-f4ab-7cfa-e053-2a91aa0a1b83 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 7610bf80-61b7-982f-e053-2a91aa0ac1bb | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.